EMFO LLC’s Precigen PGEN Stock Holding History

EMFO LLC’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$821K	Hold	519,475	–	–	0.73%	33
2024 Q1	$753K	Hold	519,475	–	–	0.69%	35
2023 Q4	$696K	Buy	519,475 +94,475	+22%	+$111K	0.64%	38
2023 Q3	$604K	Buy	425,000 +245,000	+136%	+$347K	0.57%	43
2023 Q2	$207K	Buy	+180,000	New	+$212K	0.19%	91

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EMFO LLC's PGEN Position: Q2 2024 in Review

EMFO LLC held its Precigen (PGEN) position steady in Q2 2024 at 519,475 shares worth $821K. The position accounts for 0.73% of the portfolio, ranked #33.

EMFO LLC first reported a position in PGEN in Q2 2023 and has held it in 5 quarters since. 130 funds tracked by Wall St. Rank hold PGEN as of Q2 2024.

EMFO LLC held 519,475 shares of Precigen worth $821K as of Q2 2024.
EMFO LLC left its Precigen share count unchanged in Q2 2024.
Precigen made up 0.73% of EMFO LLC's portfolio in Q2 2024, its #33 holding.
EMFO LLC first reported a position in Precigen in Q2 2023 and has held it in 5 quarters since.
130 funds tracked by Wall St. Rank held Precigen as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.